Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baby MERIT
NCT07817186Phase 3Not yet recruiting
- Sponsor
- Elevance Health
- Start
- Aug 2027
- Primary completion
- Jun 2032
01
Overview
A Phase 3 trial of trametinib in hypertrophic cardiomyopathy (HCM), RASopathy syndromes, sponsored by Elevance Health. Planned start Aug 2027; status: not yet recruiting.
02
Drugs
trametinib
03
Conditions
hypertrophic cardiomyopathy (HCM)RASopathy syndromes
Beyond the preview
Go deeper on NCT07817186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07817186.